<DOC>
	<DOCNO>NCT00748020</DOCNO>
	<brief_summary>Study two different irradiation scheme UVB phototherapy psoriasis . Previous study demonstrate similar clinical effect erythematogenic suberythematogenic irradiation , less complication suberythematogenic irradiation . Most study use irradiation scheme within patient . UVB systemic effect body . Our hypothesis previous conclusion incorrect erythematogenic scheme result earlier clearance psoriasis .</brief_summary>
	<brief_title>Narrow-Band UVB-Therapy Psoriasis</brief_title>
	<detailed_description>109 psoriasis patient , refer UVB phototherapy , participate study give write informed consent . After determine minimal erythema dose ( MED ) patient randomise either group 1 , erythematogenic scheme , group 2 , suberythematogenic scheme . Group 1 start 70 % MED every following irradiation increase 40 % . Group 2 start 30 % MED every next visit increase 20 % . The study protocol adjust case erythema ( sunburn ) accord standard erythema-phototherapy protocol , vary skip one irradiation lower percentage increase . In case clearance study stop . Clearance define less 10 % baseline body area psoriasis .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Eligible UVB phototherapy Older 18 year No topical medication 2 week No systemic medication 4 week No medication ( betablocker , lithium ) interfering psoriasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>